The Valley Desk

NCT01259817 · Interventional trial

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

Overall registry status Completed

Phase 2

Conditions High Risk Essential Thrombocythemia, High Risk Polycythemia Vera

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov